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Abstract. We have previously shown that the binding 
to cells of a monoclonal antibody directed against the 
chick neural retina N-acetylgalactosaminylphospho- 
transferase (GalNAcPTase) results in inhibition of cad- 
herin-mediated adhesion and neurite outgrowth. We 
hypothesized that the antibody mimics the action of an 
endogenous ligand. Chondroitin sulfate proteoglycans 
(CSPGs) are potential ligands because they inhibit ad- 
hesion and neurite outgrowth and are present in situ at 
barriers to neuronal growth. We therefore assayed pu- 
rified CSPGs for their ability to inhibit homophilic cad- 
herin-mediated adhesion and neurite outgrowth, as 
well as their ability to bind directly to the Gal- 
NAcPTase. A proteoglycan with a 250-kD core protein 
following removal of chondroitin sulfate chains (250- 
kD PG) inhibits cadherin-mediated adhesion and neu- 
rite outgrowth whether presented as the core protein or 
as a proteoglycan monomer bearing chondroitin sul- 
fate. A proteoglycan with a 400-kD core protein is not 
inhibitory in either core protein or monomer form. 
Treatment of cells with phosphatidylinositol-specific 
phospholipase C, which removes cell surface Gal- 
NAcPTase, abolishes this inhibitory effect. Binding of 
the 250-kD core protein to cells is competed by the 
anti-GalNAcPTase antibody 1Bll, suggesting that 
1Bll and the 250-kD core protein bind to the same site 
or in close proximity. Moreover, soluble GalNAcPTase 
binds to the immobilized 250-kD core protein but not 
to the immobilized 400-kD core protein. Concomitant 
with inhibition of cadherin mediated adhesion, binding 
of the 250-kD core protein to the GalNAcPTase on 
cells results in the enhanced tyrosine phosphorylation 
of [3-catenin  and the uncoupling of N-cadherin from its 
association with the cytoskeleton. Moreover, the 250- 
kD PG is present in embryonic chick retina and brain 
and is associated with the GalNAcPTase in situ. We 
conclude that the 250-kD PG is an endogenous ligand 
for the GalNAcPTase. Binding of the 250-kD PG to the 
GalNAcPTase initiates a signal cascade, involving the 
tyrosine phosphorylation of [3-catenin,  which alters the 
association of cadherin with the actin-containing cy- 
toskeleton and thereby inhibits adhesion and neurite 
outgrowth. Regulation of the temporal and spatial ex- 
pression patterns of each member of the GalNacPTase/ 
250-kD PG interactive pair may create opportunities 
for interaction that influence the course of develop- 
ment through effects on cadherin-based morphogenetic 
processes. 
T 
hE complex patterns of cell movements during mor- 
phogenesis are presumably guided by, and reflected 
in, the temporal and spatial patterns of expression 
of adhesion molecules. However, adhesion molecule func- 
tion may also be regulated to create temporal and spatial 
patterns guiding  morphogenetic rearrangements.  One po- 
tential  regulator  of adhesion molecule function is a  cell 
surface  N-acetylgalactosaminylphosphotransferase  (Gal- 
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NAcPTase).  1 Binding of certain monoclonal antibodies to 
the cell surface GalNAcPTase indirectly inhibits N- and 
E-cadherin  mediated  adhesion  (Balsamo  et  al.,  1991; 
Bauer et al., 1992). Furthermore, this perturbation results 
in the inhibition of neurite outgrowth in vitro, dependent 
on each of three distinct adhesive mechanisms; cadherin, 
61  integrin,  or  G4  (the  chicken  homologue  of  L1,  a 
member of the immunoglobulin/N-CAM  family) (Gaya- 
1. Abbreviations used in this paper.  GalNAcPTase, N-acetylgalactosami- 
nylphosphotransferase; ECL, enhanced chemiluminescence; GPI, glyco- 
phosphatidylinositol; NCD-2,  anti-N-cadherin antibody; PI-PLC,  phos- 
phoinositol-specific  phospholipase C. 
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GalNAcPTase  appears  to  initiate  a  signal  transduction 
pathway that ultimately has a global effect on many adhe- 
sion systems. 
This effect appears to be mediated by a change in the as- 
sociation  of  adhesion  molecules  with  the  cytoskeleton. 
The cytoplasmic domain of cadherins is  associated with 
the actin-containing network through its interaction with 
the catenins, an association essential to cadherin function 
(see Magee and Buxton, 1991; Takeichi et al.,  1992; Tsu- 
kita  et  al.,  1992;  Kemler,  1993;  Gumbiner,  1993  for re- 
views). Binding of adhesion-inhibitory anti-GalNAcPTase 
antibodies  to cells results  in  disruption  of this  essential 
linkage between cadherin and the cytoskeleton (Balsamo 
et al., 1991). 
Our working hypothesis has been that the anti-adhesive 
effect of anti-GalNAcPTase antibodies mimics the activity 
of an endogenous ligand for the GalNAcPTase and that 
the  interaction  of the  GalNAcPTase/ligand  pair  in  situ 
would have the potential to control morphogenetic pro- 
cesses. Because several proteoglycans inhibit adhesion in 
vitro,  proteoglycans are  candidate  ligands  for  the  Gal- 
NAcPTase. Both keratan sulfate and chondroitin sulfate 
proteoglycans have been reported to be inhibitors of neu- 
ronal outgrowth in vitro (Cole and McCabe, 1991; Oohira 
et al., 1991; Guo et al., 1993) and to be present at barriers 
to neuronal outgrowth in situ (Oakley and Tosney, 1991; 
Pinzola et al., 1993; Geisert and Bidanset, 1994; see also 
Schwab et al.,  1993; Margolis and Margolis, 1993  for re- 
views). Furthermore, it has been suggested that proteogly- 
cans act as  "anti-adhesion" molecules by binding to cell 
surface  receptors  and  thereby initiating  transmembrane 
signals that alter the structure of the cytoskeleton, result- 
ing in  the  inhibition  of cell spreading  and  migration in 
vitro (Hoffman et al., 1994). 
It is controversial whether the anti-adhesive effects of 
proteoglycans are due to nonspecific interference with cell 
apposition,  resulting  in  lack  of appropriate  contact  be- 
tween adhesion molecules on adjacent cells (Morris, 1993; 
Vleminckx et al., 1994), or result from the specific interac- 
tions  of proteoglycans with  cell  surface  receptors.  Re- 
cently,  chondroitin  sulfate  proteolycans  have  been  ob- 
served  to  bind  to  cell  surface  receptors  and  to  inhibit 
adhesion by two distinct mechanisms: (a) Homophilic ad- 
hesion mediated by N-CAM or Ng-CAM is inhibited by 
the direct binding of neurocan (a rat brain-derived pro- 
teoglycan) to N-CAM or Ng-CAM (Grumet et al.,  1993). 
(b)  Cell-extracellular matrix adhesion mediated by inte- 
grins is inhibited by an indirect mechanism involving the 
binding of chicken brain proteoglycans with 400- and 250- 
kD core proteins to cell surface receptors other than the 
integrin subunits themselves (H. Ernst, M. K. B. Zanin, D. 
Everman, and S. Hoffman, manuscript submitted for pub- 
lication). 
The ability of the 400- and 250-kD proteoglycans of H. 
Ernst,  M.  K.  B.  Zanin,  D.  Everman,  and  S.  Hoffman, 
(manuscript submitted for publication) to initiate a signal 
which affects adhesion involving other ligands is similar to 
the effects produced by select anti-GalNacPTase antibod- 
ies following binding to the GalNAcPTase (Balsamo et al., 
1991).  Therefore, we tested whether these proteoglycans 
might be endogenous ligands for the GalNAcPTase. We 
found that the proteoglycan with the 250-kD core protein 
(250-kD  PG) binds  directly to the  GalNAcPTase at the 
cell surface, resulting in inhibition of homophilic cadherin- 
mediated adhesion, as well as neurite outgrowth. In con- 
trast,  the  proteoglycan  with  the  400-kD  core  protein 
(400-kD PG) has little or no effect. We further show that 
incubating cells with the 250-kD PG, but not the 400-kD 
PG, alters the tyrosine phosphorylation state of 13-catenin 
and the association of cadherin with actin, providing a rea- 
sonable mechanism for the inhibition of cadherin-medi- 
ated adhesion by the GalNAcPTase/250-kD PG interac- 
tive pair. This interactive pair may play an important role 
in  modulating  morphogenetic movements by regulating 
the function of cadherins and potentially other adhesion 
molecules. 
Materials and Methods 
Antibodies 
Anti-GalNAcPTase  antibodies  1Bll  and  7A2  are  mouse  monoclonal 
IgMs prepared as described (Scott et al., 1990; Balsamo et al., 1991). Ceils 
producing anti-N-cadherin antibody NCD-2  (a gift  from M.  Takeichi) 
were cultured in our laboratory and the antibody prepared as described 
(Balsamo et al., 1991). The anti-13-catenin  antibody was prepared in rab- 
bits from the following synthetic 15-amino acid peptide deduced from the 
published cDNA sequence (Butz et al., 1992): CPGDSNQLAWFDTDL. 
The anti-phosphotyrosine antibody clone PY20 was from Transduction 
Laboratories  (Lexington,  KY).  Anti-actin  antibody  was a  monoclonal 
IgM purchased from Amersham Corp. (Arlington Heights, IL). As con- 
trois, commercial mouse IgM or rabbit IgG were purchased from Sigma 
Immunochemicals (St. Louis, MO). 
To prepare anti-proteoglycan antibodies, total chicken brain proteogly- 
can monomers were isolated as described below and were used to immu- 
nize  rabbits. This avoids making antibodies against the highly antigenic 
and cross-reactive stubs of chondroitin sulfate that remain on chondroitin 
ABC lyase-treated core proteins. Antibodies specific for the 250 and 400- 
kD  core  proteins were  then  affinity  purified.  Core  proteins  were  co- 
valently  linked  to CNBr-activated  Sepharose 4B  (Pharmacia LKB  Nu- 
clear,  Gaithersburg, MD) following the manufacturer's instructions using 
50 ~g of protein per ml of beads. 10 mg of anti-proteoglycan IgG (isolated 
from serum as described by Brackenbury et al.,  1977) was dissolved in 
PBS and run over a column containing 1 ml of immobilized 250-kD  core 
protein. After extensive washing with PBS, bound IgG was eluted with 50 
mM diethylamine. The diethylamine eluate was neutralized with 1/10 vol 
of I  M sodium phosphate (pH 6.3), then run over a column containing 1 
ml of immobilized 400-kD  core protein. Both the unbound fraction and 
the bound and eluted fraction from this second column were saved and 
characterized in terms of their reactivity on Western transfers of embry- 
onic brain extracts. As expected, IgG retained on the immobilized 250-kD 
core protein, but not retained on the immobilized 400-kD  core protein, 
recognized the 250-kD core protein but not the 400-kD  core protein and is 
referred to as anti-250.  IgG bound and eluted from the 250-kD  core pro- 
tein, then bound and eluted from the 400-kD  core protein recognized the 
400-kD core protein, but not the 250-kD  core protein, and is therefore re- 
ferred to as anti-400.  The fact that the anti-400  antibody was retained by 
the immobilized 250-kD  core protein appears to result from the presence 
of partially degraded 400-kD  core proteins in the 250-kD  core protein 
preparation. This is supported by data from NH2-terminal sequence anal- 
yses of CNBr fragments derived from the 250-kD  core protein prepara- 
tion (see Discussion). The patterns of reactivity  of the anti-250  and anti- 
400 antibodies on brain and retina extracts are shown in Fig. 8. 
Preparation of Proteoglycan Fractions 
Proteoglycan fractions were prepared as recently described (H. Ernst, 
M. K. B. Zanin, D. Everman, and S. Hoffman, manuscript submitted for 
publication). Briefly,  14-d-old  embryonic chicken brains were homoge- 
nized and the supernatant was fractionated on CsC1 density gradients un- 
der nondenaturing conditions. The densest material from the CsCl gradi- 
ents,  when  fractionated  by  HPLC  gel  filtration  under  nondenaturing 
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teoglycan aggregates and a  lower  molecular weight fraction containing 
proteoglycan monomers. In addition, each of these fractions contains the 
glycoprotein restriction. We refer to the lower molecular weight fraction 
as native monomers because it was never exposed to hyaluronidase, Ap- 
proximately 75 % of the proteoglycan monomers with core proteins of 400 
and 250 kD are isolated in the native monomer fraction, while only 25% 
are isolated in the aggregate fraction (Ernst et al., manuscript submitted 
for publication), suggesting that proteoglycans are present both in aggre- 
gates and as monomers in vivo. To purify the major proteoglycan mono- 
mers and core proteins individually, the dense fraction from the CsC1 gra- 
dients  was  digested  with  Streptomyces  hyaluronidase.  Restrictin  was 
separated from the proteoglycan monomers by rate-zonal sedimentation 
on  sucrose gradients.  Proteoglycan monomers containing 400-kD  core 
proteins  and proteoglycan monomers containing 250-kD  core  proteins 
were then separated by HPLC gel filtration in the presence of 4 M guani- 
dine-HCl. To isolate core proteins, the proteoglycan monomers from the 
sucrose gradient were treated with chondroitin ABC lyase, and the 400- 
and 250-kD core proteins resolved by HPLC gel filtration in the presence 
of 4  M  guanidine-HC1. These preparations  are  referred  to  as  400-kD 
monomer, 250-kD monomer, 400-kD core protein, and 250-kD core pro- 
tein. When describing the form of one of these proteoglycan preparations 
present in vivo or when referring to both the monomer and core protein of 
a proteoglyean, these proteoglycans will be referred to as 400-kD PG and 
250-kD PG. 
Preparation of Single Cells and Adhesion Assays 
For adhesion assays, E8 neural retina tissue was incubated overnight at 
37°C in leucine-free F12 medium (GIBCO BRL, Gaithersburg, MD) con- 
taining 10 ixCi/ml of [3H]Leucine (53 Ci/mM; DuPont NEN, Boston MA). 
Single cells were prepared by trypsinization of tissues in the presence of 1 
mM Ca  2+ (Grunwald et al., 1980; Brackenbury et al., 1981; Magnani et al., 
1981).  The radiolabeled  cells were resuspended in HBSGKCa (20 mM 
Hepes, pH 7.4, 150 mM NaCl, 2 mM glucose, 3 mM KCI, and 1 mM CaCl2) 
at a concentration of 1 ×  106/ml. Cells were incubated with the appropriate 
additives in HBSGKCa in a total volume of 200 p.l for 15 min at 4°C; 50-~1 
aliquots were then added to each well of a 96-well plate (previously coated 
with  purified  N-cadherin  [~0.1  txg/well]  or  anti-N-cadherin  antibody 
NCD-2 [5  i~g/well])  and incubated for 30 min at 37°C (Balsamo et  al., 
1991).  The wells were washed 4×  with HBSGKCa containing 1 mg/ml 
BSA (HBSGKCaBSA), the attached cells solubilized in 0.1 N NaOH, and 
radioactivity determined by liquid scintillation counting. To determine the 
effect on adhesion of treating cells with phospholipase 3H-labeled cells 
were incubated with 5 u/ml of phosphoinositol-specific phospholipase C 
(PI-PLC) for 30 min at 37°C before assay, as described previously (Bal- 
samo and Lilien, 1993). 
Assay for Neurite Outgrowth 
These assays were performed essentially as described (Gaya-Gonzalez et 
al., 1991).  N-cadberin was prepared from El0 chick neural retinas by af- 
finity purification on anti-N-cadherin antibody (NCD-2)  conjugated to 
CNBr-Sepharose as described by Bixby and Zhang (1990).  Single cells 
prepared by trypsinization of E7 neural retinas were plated in each well of 
24-well plates (previously coated with affinity-purified N-cadherin [100 p.l 
of a solution of 1 p.g/ml])  and allowed to adhere for a period of 2 h. Ali- 
quots of the appropriate additives were then added and the cells were cul- 
tured for another 20 h. After this time, the cells were observed using an 
Olympus inverted microscope. Cells bearing extensions shorter than one 
cell diameter were considered negative for neurite extension. 50-70 cells 
were counted for each treatment in three different experiments. To test 
for the effect of treatment with phospholipase, cells were treated with PI- 
PLC as described above before plating onto the N-cadherin-coated wells. 
Binding of Radiolabeled Proteoglycan 
Core Proteins to Cells 
lZSl-labeled  proteoglycan core proteins were prepared using the chlora- 
mine T method according to Friedlander et al. (1988). For binding assays, 
single cells were resuspended in HBSGKCaBSA and aliquots containing 
1 ×  105 cells were plated into individual wells of 96-well plates precoated 
with poly-L-lysine (100 p,1 of a solution of 50 p,g/ml). The wells were then 
washed with poly-L-glutamic acid to block nonspecific binding to the poly- 
L-lysine substrate (blocking of nonspecific binding was also reduced by the 
presence of BSA in the cell suspension during formation of the cell layer 
and during incubation with iodinated proteoglycan). The wells were incu- 
bated with increasing concentrations of radiolabeled 250- or 400-kD core 
proteins in a total volume of 100 Ixl of HBSGKCaBSA for 30 min at 4°C. 
Unbound material was removed and the wells were washed 4× with 200 
i~1 of HBSGKCaBSA. The cell layers were solubilized in 0.1 N NaOH and 
bound radioactivity was determined by liquid scintillation counting. 
Binding of the GalNAcPTase to Immobilized 
Proteoglycan Core 
Immobilized core proteins were prepared as described above for the affin- 
ity purification of antibodies. GalNAcPTase and other GPf-anchored cell 
surface proteins were released from crude cell membranes from 20 El0 
retinas using 10 U/ml PI-PLC as previously described (Balsamo and Lil- 
ien, 1993). Following centrifugation at 150,000 g the supernatant (200 ~1 in 
20 mM Hepes [pH 7.4], 0.15 M NaC1, 1 mM PMSF, 1.5 p,g antipain, 25 ~g 
DNAase) was incubated with sulfo-NHS-Biotin (1 mg/ml; Pierce Chem. 
Co., Rockford, IL) for 30 min at room temperature. Unreacted and inacti- 
vated biotin was removed by microconcentration (Centricon 10; Millipore 
Corp.,  Bedford,  MA).  250-1xl aliquots containing the material released 
from 10 retinas were incubated with 50 ~1 of packed beads for 1 h at 4°C. 
Unbound material was collected and concentrated for analysis by SDS- 
PAGE. The beads were washed 3× with 10 mM Tris-HC1 (pH 8.0) con- 
taining 150 mM NaC1, 0.1% Triton X-100 and 0.1% BSA, and bound ma- 
terial eluted with SDS sample buffer (0.125 M Tris-HC1 [pH 6.8], 2% SDS, 
5 % ~-mercaptoethanol, and 10% glycerol). The total bound and unbound 
material were fractionated by SDS-PAGE and transferred to Immobilon. 
To detect the GalNAcPTase, the transfers were reacted with anti-Gal- 
NAcPTase antibody followed by HRP-conjugated goat anti-mouse IgM 
and developed using the enhanced chemiluminescence (ECL)  substrate 
(Amersham). Biotinylated species in the bound and unbound fractions 
were detected with alkaline phosphatase conjugated avidin. 
GalNAcPTase bound to  beads was  also measured by  assaying Gal- 
NAcPTase activity. Material  released from 20  El0  retinas  by  PI-PLC 
treatment was incubated with 100 Ixl of packed beads bearing either the 
250- or the 400-kD core proteins. Bound GalNAcPTase was assayed by 
measuring the  incorporation  of  [3H]-GalNAc  from  UDp[3H]-GalNAc 
into  asialo-agalactofetuin as described previously (Balsamo and Lilien, 
1982). 
Effect of the 250-kD Core Protein on the Association 
of N-cadherin with Actin 
The effect of the 250- or 400-kD core proteins on the association between 
N-cadherin and actin was determined as previously described (Balsamo et 
al., 1991).  1 x  108 single cells were incubated in 2 ml of HBSGKCa con- 
taining 10 ixg/ml of the 250- or 400-kD core proteins for 30 min, at 37°C 
and 120 rpm. The cells were pelleted, washed in HBSGKCa and homoge- 
nized in homogenization buffer (1% Triton X-100, 50 mM Tris-HC1 [pH 
7.4], 0.15 M NaC1,  1 mM PMSF, 5 p.g/ml each of antipain, leupeptin, and 
chymostatin, 1 mM NaF, 4 mM o-vanadate, 1 mM EDTA, and 100 ~g/ml 
DNAase).  After  30  min on ice,  the homogenates were  centrifuged at 
14,000 g and the supernatants layered onto 1 ml of 20% sucrose on top of 
100 p.1 of 50% sucrose each made in 1% Triton X-100, 50 mM Tris-HCl 
[pH 7.4], 0.15 M NaC1, and centrifuged at 150,000 g for i  h. The 50% layer 
and the 20/50% interface were collected (referred to as the rapidly sedi- 
menting fraction; see Balsamo et al., 1986), diluted with an equal volume 
of homogenization buffer, and incubated with anti-actin antibody for 4 h 
at 4°C with gentle rocking. The samples were then incubated with goat 
anti-mouse IgG conjugated to magnetic beads (Advanced Magnetics Inc., 
Cambridge, MA) for another hour, the beads collected using magnetic 
stands, washed 3×  in homogenization buffer containing 0.1%  SDS and 
1% BSA, then 3 × in homogenization buffer and once in H20. The immu- 
noprecipitated material was eluted in SDS sample buffer, fractionated by 
SDS-PAGE, transferred to Immobilon, reacted sequentially with anti-N- 
cadherin monoclonal antibody NCD-2 and HRP-conjugated goat anti-rat 
antibody, and detected using the ECL procedure. 
Effect of GalNAcPTase Ligands on 
[3-catenin Phosphorylation 
To examine the effects of core proteins or anti-GalNAcPTase mAbs on 
the phosphorylation of 13-catenin, single cells (N1 ×  108 cells in 2 ml) were 
incubated in HBSGKCa for 30 min at 37°C and 120 rpm in the presence of 
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ml). The ceils were collected and homogenized in homogenization  buffer 
and the rapidly sedimenting fraction isolated. This fraction was made 1% 
in SDS, boiled to dissociate the complex, diluted  to 0.1% SDS with ho- 
mogenization buffer, and incubated  with anti-13-catenin antibody for 4 h 
at 4°C. The samples were then incubated with goat anti-rabbit antibody 
conjugated  to magnetic  beads and the immunoprecipitates  collected  as 
described above, fractionated  by SDS-PAGE, transferred to Immobilon, 
reacted sequentially  with anti-phosphotyrosine  antibody  and HRP-con- 
jugated  goat  anti-mouse IgG,  and  developed using  the  ECL system. 
The same  transfers  were stripped and probed with anti-13-catenin anti- 
bodies and developed with alkaline-phosphatase  conjugated  goat anti- 
rabbit IgG. 
Preparation of Tissue Extracts for Western Blots with 
Anti-250 and Anti-400 
E9 brain or retina tissue was homogenized  in 10 vol of 0.1 M Tris-HCl (pH 
8.0) containing protease inhibitors (10 rnM N-ethylmaleimide, 5 mM benz- 
amidine, 50 p~g/ml  leupeptin, 1 p~g/ml  aprotinin, 5 ixg/ml  pepstatin A, and 2 
mM PMSF and the homogenates centrifuged at 14,000 rpm for 5 min. A 
portion of the resulting  supernatant was then treated with chondroitin 
ABC lyase (0.5 u/ml) for 30 min at 37°C. The protein concentration  in the 
extracts was determined using the BCA assay (Pierce). 25-I-Lg aliquots of 
each sample were fractionated  by SDS-PAGE, transferred to nitrocellu- 
lose, reacted sequentially with anti-250 or anti-400 and HRP-conjugated 
goat anti-rabbit antibodies, and detected using the ECL substrate. 
Coprecipitation of the GalNAcPTase, the 250-kD Core 
Protein and N-cadherin  from Tissue 
The rapidly sedimenting fraction isolated from 20 retinas (1 ml), prepared 
as described above, was treated with 0.5 U chondroitin ABC lyase (Seika- 
gaku  Corp., Tokyo, Japan) for 30 min at 37°C. Equal volume  aliquots 
were incubated  with anti-GaINAcPTase  mAb 1Bll, anti-250, or control 
nonimmune mouse IgM or rabbit IgG for 4 h at 4°C. Immunoprecipitates 
were collected using the appropriate second antibodies as described above 
and washed 3×  in 10 mM Tris-HCl (pH 7.4), containing  150 mM NaC1, 
1% Triton X-100, and 1% BSA, then 3 × in the same buffer but containing 
only 0.1% Triton X-100 and 0.1% BSA. The antigen was eluted from the 
magnetic  beads by boiling in SDS sample buffer,  fractionated  by SDS- 
PAGE, transferred to Immobilon  (Millipore),  reacted sequentially  with 
the antibodies indicated in Fig. 9 and appropriate HRP-conjugated  second 
antibodies, and detected using the ECL procedure. 
Results 
In these studies we examine the ability of proteoglycan ag- 
gregates, monomers, and core proteins to inhibit cadherin- 
mediated  adhesion  and neurite outgrowth of embryonic 
chick neural retina cells when added to the culture me- 
dium. The purification scheme and the composition of the 
proteoglycan fractions tested are as recently described (H. 
Ernst,  M.  K.  B.  Zanin,  D.  Everman,  and  S.  Hoffman, 
manuscript submitted for publication). These methods and 
the nomenclature used in this paper are summarized in the 
Materials and Methods. 
We have used both purified N-cadherin and anti-N-cad- 
herin mAb NCD-2 as the substrate for cell adhesion and 
neurite outgrowth; they are both highly active in their abil- 
ity to mediate these processes (Balsamo et al., 1991; Gaya- 
Gonzales et al., 1991). All of the assays reported here have 
been performed using both substrates  with identical re- 
suits. 
Inhibition of  N-cadherin-mediated  Adhesion 
by Proteoglycans 
We first compared the ability of proteoglycan aggregates 
and native monomers to affect cadherin-mediated adhe- 
sion. Native monomers inhibit cadherin mediated  adhe- 
sion to either purified N-cadherin or to the anti-N-cad- 
herin antibody NCD-2 (Fig. 1 A). Furthermore, inhibition 
of cadherin mediated adhesion by the native proteoglycan 
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Figure 1. Inhibition of N-cadherin-mediated adhesion by native 
chick brain proteoglycan monomers. The adhesion of 3H-labeled 
cells to purified N-cadherin or anti-N-cadherin antibody-coated 
96-well plates was evaluated in the presence of the indicated ad- 
ditives in the culture fluid. Adhesion is represented as the percent 
of the adhesion obtained with no additives. Up to 70%  of the 
added cells attach under control conditions. The data are repre- 
sentative of several experiments, each point is  the  average  of 
three measurements. Error bars indicate the standard error of the 
mean. (A) Adhesion before or after treatment of cells with PI- 
PLC. CO, control, no additives; 1Bll, anti-GalNAcPTase mAb 
1Bll  (10  ~g/ml); Mono, native proteoglycan monomer mixture 
(15 p~g/ml); NCD-2, anti-N-cadherin mAb (10 pLg/ml). (B) Adhe- 
sion to anti-N-cadherin antibody in the presence of increasing 
concentrations of the native proteoglycan monomer mixture. [~, 
control cells (Co); 0, cells treated with PI-PLC (PL). 
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Figure 2.  Effect  of purified  proteoglycan  monomers  and  core 
proteins on N-cadherin-mediated  adhesion. The adhesion of 3H- 
labeled cells to anti-N-cadherin-coated  96-well plates was evalu- 
ated in the presence of increasing concentrations of the indicated 
purified chick brain proteoglycan monomers (250 kD mono.  and 
400 kD mono.) or core proteins (250 kD core and 400 kD core) in 
the culture fluid. Adhesion is represented  as the percent  of the 
adhesion obtained  in wells with no additives. Each point repre- 
sents the average of three measurements. Error bars indicate the 
standard error of the mean. 
monomers is dose dependent (Fig.  1 B).  In contrast, the 
hyaluronic  acid-containing  aggregates  are  inactive,  sug- 
gesting that the moieties responsible for triggering the in- 
hibition of cadherin-mediated adhesion are masked in the 
aggregate (not shown). Because PI-PLC removes the Gal- 
NAcPTase from the cell surface and abolishes the ability 
of anti-GatNAcPTase mAb 1Bll to inhibit cadherin-me- 
diated  adhesion (Balsamo and Lilien,  1993),  we assayed 
the effect of native monomers on cadherin-mediated ad- 
hesion  using  PI-PLC-treated cells.  With  these  cells  the 
native  monomers  no  longer  inhibit  cadherin-mediated 
adhesion; however, anti-N-cadherin mAb NCD-2 is  still 
inhibitory (Fig. 1 A). These data suggest that a component 
of the  native  monomer preparation interacts  with  a  cell 
surface polypeptide containing a  glycophosphatidylinosi- 
tol (GPI) tail, possibly the GalNAcPTase. 
To determine which component of the native monomer 
preparation is  active in inhibiting cadherin-mediated ad- 
hesion, we evaluated the activity of the 400- and 250-kD 
monomer and core protein preparations. Only the 250-kD 
monomer and core protein preparations show significant 
inhibition of N-cadherin-mediated adhesion (Fig. 2). 
The 250-kD Core Protein Inhibits Neurite 
Extension on N-cadherin 
We  have  previously shown  that  E7  chick  neural  retina 
cells extend neurites when plated on purified N-cadherin 
or anti-N-cadherin antibody NCD-2 and that addition of 
anti-GalNAcPTase mAb 1Bll inhibits this neurite exten- 
sion by ~70%  (Gaya-Gonzalez, 1991).  The 250-kD core 
protein is as effective as anti-GalNAcPTase mAb 1Bll in 
inhibiting  neurite  extension.  Only  18%  (_+4%)  of cells 
bear neurites in the presence of the 250-kD core protein, 
as opposed to 77% (_+3%) in the absence of additives. The 
percent of cells with neurites in the presence of the 400-kD 
core protein is similar to the controls (67 _+ 9%). 
Representative fields of cells cultured on purified N-cad- 
herin with or without the addition of the 250-kD core pro- 
tein or anti-GalNAcPTase mAb 1Bll are shown in Fig. 3. 
As described above for cell adhesion, the inhibitory effect 
of the 250-kD core protein and anti-GalNAcPTase mAb 
1Bll are eliminated by treating the cells with PI-PLC (Fig. 
Figure 3. Effect of the 250-kD core protein on neurite extension. E7 chick neural retina cells (A-D, control cells; E-H, PI-PLC-treated 
ceils) were plated on 24-well plates coated with affinity purified N-cadherin and allowed to adhere for 2 h. Culture medium containing 
the indicated components was added and the cells incubated for 20 h. (A and E) No additives; (B and F) 250-kD core protein (15 p~g/ml); 
(C and G) anti-GalNAcPTase mAb 1Bll (10 ixg/ml); (D and H) anti-N-cadherin  mAb NCD-2 (10 ixg/ml). Bar, 50 t~m. 
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cadherin mAb  NCD-2  inhibits neurite  outgrowth  before 
and  after PI-PLC  treatment  of cells (Fig. 3,  compare  D 
with H). As in the case of adhesion, the 400-kD core pro- 
tein does not inhibit neurite outgrowth (data not shown). 
These results further highlight that the interaction of the 
250-kD core protein (and mAb 1Bll) with the cell surface 
involves a GPI-anchored receptor. 
The 250-kD Proteoglycan Core Protein 
Binds to Cells 
The  results described above are consistent with the idea 
that the 250-kD core protein binds to a cell surface recep- 
tor, possibly the GalNAcPTase. To demonstrate that this 
is indeed the case, we assayed the binding of 125I-labeled 
250- and 400-kD core proteins to cells. Binding of the 250- 
and  400-kD  core  proteins  increases  with  concentration; 
however, a  much higher level of binding is observed with 
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Figure 4. Binding of the 250-kD core protein to cells and inhibi- 
tion by the  anti-GalNAcPTase mAb 1Bll. Cells attached to a 
poly-L-lysine coated substrate were incubated with radiolabeled 
core proteins (170,000  cpm/l~g protein), washed, and the bound 
radioactivity  determined. Each point is the average of three mea- 
surements. Error bars represent the standard error of the mean. 
(A) 250-kD  core protein (open squares); 400-kD  core protein 
(closed  circles). (B)  increasing  concentrations  of  anti-Gal- 
NAcPTase mAbs 1Bll (open squares)  or 7A2 (filled circles) were 
added to cells followed by the addition of 30 ng of radiolabeled 
250-kD core protein. 
the 250-kD core protein (Fig. 4 A). Based on the amount 
of label bound to cells incubated with 100 ng/ml of the 250- 
kD core protein (at which concentration the binding curve 
is approaching an asymptote), there appear to be ~1  x  105 
receptors for the 250-kD  core protein per cell. These re- 
suits are consistent with the presence of a specific receptor 
for the 250-kD core protein at the cell surface. 
Binding of the 250-kD monomer or core protein to cells 
has  the  same  effect  on  cadherin-mediated adhesion  and 
neurite outgrowth as binding of anti-GalNAcPTase mAb 
1Bll  (Balsamo  et  al.,  1991;  Gaya-Gonzalez, 1991).  This 
observation  suggests  that  the  250-kD  core  protein  and 
mAb 1Bll might bind to the same critical site on the Gal- 
NAcPTase. To test this possibility, we measured the bind- 
ing of a  subsaturating amount of 125I-labeled 250-kD core 
protein to  cells in  the  presence  of increasing concentra- 
tions of mAb 1Bll. As a  control, we replaced mAb 1Bll 
with mAb 7A2, which also binds to the cell surface Gal- 
NAcPTase but does not inhibit cadherin-mediated adhe- 
sion (Balsamo et al., 1991).  Binding of 250-kD  core pro- 
tein is inhibited by mAb 1Bll, while mAb 7A2 has little 
effect (Fig. 4 B), strongly suggesting that the 250-kD core 
protein and mAb  1Bll  bind to the  same, or an overlap- 
ping, site on the GalNAcPTase. 
The 250-kD Core Protein Binds to 
the GalNAcPTase 
The results presented thus far, that the binding of the 250- 
kD  core  protein  to  cells is  inhibited  by mAb  1Bll  and 
eliminated by treatment of cells with PI-PLC, are consis- 
tent with the GalNAcPTase being a  cell surface receptor 
for the 250-kD core protein. To verify that the two mole- 
cules interact directly, we tested the ability of the 250-kD 
core  protein  covalently attached  to  Sepharose  beads  to 
bind soluble GalNacPTase released from El0 neural ret- 
ina membranes  by treatment with PI-PLC  (Balsamo and 
Lilien,  1993).  As  a  control  for  nonspecific  adsorption, 
Figure 5. Binding of the GalNAcPTase to immobilized core pro- 
teins. The GalNAcPTase, along with other GPI-linked proteins, 
was released by PI-PLC treatment of crude membranes from El0 
retina tissue and was labeled with biotin. This released material 
was then incubated with immobilized 250-  or 400-kD core pro- 
teins. Unbound (Flow or F) and bound and eluted (Bound or B) 
material was fractionated by SDS PAGE, transferred to Immo- 
bilon,  and  immunoblotted  with:  (A)  anti-GalNacPTase  mAb 
1Bll,  or  (B)  alkaline phosphatase-conjugated  avidin.  Arrow- 
heads labeled Tase indicate the migration of the GalNAcPTase. 
The 180-kD polypeptide recognized by anti-GalNAcPTase anti- 
body is a fragment of the 220-kD GalNAcPTase (J. Balsamo and 
J.  Lilien, unpublished). The migration of standard proteins for 
both panels is indicated at the left of A by their molecular mass. 
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were used. A  comparison of bound and unbound material 
by Western blotting with anti-GalNAcPTase antibody re- 
veals that the GalNAcPTase is bound by the immobilized 
250-kD core protein, but not by the immobilized 400-kD 
core protein (Fig. 5 A). Similarly, the GalNAcPTase is re- 
moved from solution by the immobilized 250-kD core pro- 
tein, but not by the immobilized 400-kD core protein (Fig. 
5 A). Moreover, the GalNAcPTase appears to be the pre- 
dominant polypeptide bound by the immobilized 250-kD 
core protein  (Fig.  5  B).  Whereas a  polypeptide with the 
migration of the GalNAcPTase is one of four major poly- 
peptides released by PI-PLC, it is the predominant polypep- 
tide bound by the 250-kD core protein. 
The  differential  binding  of  the  GalNAcPTase  to  the 
250- and 400-kD core proteins was also measured by as- 
saying  the  amount  of  GalNAcPTase  activity  associated 
with the beads. Consistent with the Western blot data, no 
GalNAcPTase  activity  above  background  is  associated 
with  the  immobilized  400-kD  core  protein  (<3.5  pmol 
GalNAc incorporated per 100  txl of packed beads), while 
the  GalNAcPTase  associated  with  the  immobilized 250- 
kD  core  protein  catalyzed the  incorporation  into  asialo- 
agalactofetuin of 13 pmol of labeled GalNAc per 100 ~1 of 
packed beads. 
Binding of 250-kD Core Protein to Cells Alters the 
Association  of N-cadherin  with Actin 
We have previously shown that the inhibition of cadherin- 
mediated adhesion by binding of anti-GalNAcPTase mAb 
1Bll  to  cells  is  accompanied  by  uncoupling  of N-  and 
E-cadherin from their association with the  actin-contain- 
ing cytoskeleton (Balsamo et al., 1991; Bauer et al., 1992). 
This association is critical to cadherin function (see Magee 
and  Buxton,  1991;  Takeichi  et  al.,  1992;  Tsukita  et  al., 
1992;  Kemler, 1993;  Gumbiner, 1993  for reviews). To de- 
termine if binding of the 250-kD core protein also uncou- 
ples the association of N-cadherin with the actin-contain- 
ing  cytoskeleton,  cells  were  incubated  with  the  250-  or 
450-kD  core  proteins,  homogenates  prepared,  and  frac- 
tionated on sucrose gradients. In unperturbed cells, N-cad- 
herin  can  be  precipitated  from  the  rapidly  sedimenting 
fraction by anti-actin antibodies, suggesting that a complex 
containing  actin,  N-cadherin,  and  the  GalNAcPTase  is 
found in this fraction (Balsamo et al., 1991).  Similarly, in 
cells incubated with the 400-kD core protein, N-cadherin 
is precipitated from the rapidly sedimenting sucrose gradi- 
Figure 6. Effect of the 250-kD core 
protein on the association of N-cad- 
herin with actin. Cells incubated with 
soluble  250- or  400-kD  core  pro- 
teins  were homogenized.  The rap- 
idly  sedimenting  fraction was  iso- 
lated and incubated with anti-actin 
antibody. The resulting immunoprecipitates were fractionated by 
SDS-PAGE, transferred to Immobilon, and immunoblotted with 
anti-N-cadherin mAb NCD-2. The arrowhead labeled N-cad in- 
dicates  the position of N-cadherin.  The migration of standard 
proteins is indicated  by their molecular mass. The lower molecu- 
lar mass bands seen in both lanes are due to recognition  of the 
precipitating  antibody by the secondary antibody conjugate. 
ent fraction by anti-actin antibodies (Fig. 6). However, in 
the rapidly sedimenting fraction from cells incubated with 
the 250-kD core protein, no detectable N-cadherin copre- 
cipitates  with  actin  (Fig.  6).  The  amount  of  actin  pre- 
cipitated  is  similar in  all  cases  (not  shown).  These  data 
strongly suggest that binding of the 250-kD core protein to 
the GalNAcPTase uncouples N-cadherin from its associa- 
tion with the actin-containing cytoskeleton. 
Binding of GalNAcPTase Ligands to Neural Retina 
Cells Results in Increased Levels of  Phosphorylated 
Tyrosine in fl-catenin 
Phosphorylation  of [3-catenin has previously been corre- 
lated with the loss of cadherin function (Matsuyoshi et al., 
1992; Behrens et al., 1993; Hamaguchi et al., 1993; Shiba- 
moto et al., 1994). Because the binding of GalNAcPTase 
ligands to cells inhibits cadherin function, we also exam- 
ined their effect on the tyrosine phosphorylation of [3-cate- 
nin. El0 cells were incubated with the 250-kD core protein 
or  the  anti-GalNAcPTase  mAb  1Bll.  As  controls,  the 
cells were incubated with the 400-kD core protein and the 
anti-GalNAcPTase mAb that  binds  but  does not  inhibit 
adhesion  (mAb 7A2).  The  rapidly sedimenting  fractions 
from each of the  cell homogenates were incubated  with 
anti-N-cadherin  mAb  NCD-2  to  precipitate  N-cadherin 
and the associated catenins. Under these conditions no ty- 
rosine  phosphorylated proteins  are  detected  in  material 
from cells treated with the 400-kD core protein or mAb 
7A2 and only one polypeptide at ~93 kD, the molecular 
mass of [3-catenin,  is  seen in  material from cells treated 
with the 250-kD core protein or mAb 1Bll  (not shown). 
To  unequivocally  identify  this  tyrosine-phosphorylated 
polypeptide  as  13-catenin,  the  same experiment was per- 
formed using  anti-[3-catenin  as  the  immunoprecipitating 
antibody. Little or no phosphorylated [3-catenin is seen in 
the absence of treatment (not shown)  or following treat- 
ment  of the  cells with  the  400-kD  core  protein  or mAb 
7A2; however, following incubation with the 250-kD core 
protein  or anti-GalNAcPTase mAb  1Bll,  high levels of 
tyrosine-phosphorylated  [3-catenin  are  detected  (Fig.  7, 
Figure 7.  Effect of anti-Gal- 
NAcPTase  mAb  1Bll  and 
the  250-kD  core protein  on 
the  level  of phosphorylated 
tyrosine in  [3-catenin. Single 
ceils  were  incubated  with 
anti-GalNAcPTase mAbs 7A2 
or 1Bll  or the 250- or 400- 
kD  core  proteins.  The  cells 
were then homogenized,  the 
rapidly sedimenting  fraction 
isolated,  treated with  SDS, and incubated with  anti-B-catenin 
antibody. The anti-[3-catenin immunoprecipitates from the indi- 
cated cell preparations were fractionated by SDS-PAGE, trans- 
ferred to Immobilon, and immunoblotted with anti-phosphoty- 
rosine antibody (top) or anti-[3-catenin  antibody (bottom). The 
arrowheads labeled 13 cat.  indicate  the migration of [3-catenin. 
The migration of standard proteins is indicated  on the left by 
their molecular mass. The lower molecular mass bands seen in 
all lanes of the upper panel are due to recognition  of the precipi- 
tating antibody by the secondary antibody conjugate. 
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in the  amount of precipitated  [3-catenin  as evidenced by 
the  fact  that  similar  levels  of [3-catenin  protein  are  de- 
tected in all four immunoprecipitates using anti-~-catenin 
as the detecting antibody on Western blots (Fig.  7, lower 
panel). An increase in phosphorylated tyrosine residues on 
[3-catenin is also seen following incubation of cells with the 
250-kD monomer (not shown). 
The 250-kD Monomer Is Associated with the 
GalNAcPTase in Tissue 
We have shown that the isolated chick brain-derived 250- 
kD  monomer and  core protein  bind  to  the  cell  surface 
GalNAcPTase in vitro, initiating a signal that results in in- 
creased levels of phosphorylated tyrosine in 13-catenin, un- 
coupling of N-cadherin from its association with actin, and 
loss of N-cadherin function. If the 250-kD monomer is in- 
deed  an  endogenous  ligand  for  the  GalNAcPTase,  it 
should  be  present  in  vivo in  retina,  possibly  associated 
with the GalNAcPTase. To confirm that the 250-kD (and 
400-kD) monomers are present in retina, affinity-purified 
antibodies specific for the 250-  and 400-kD core proteins 
were prepared and used in Western blotting experiments 
with E9 brain and retina extracts.  The anti-250 antibody 
recognizes a  250-kD core protein in retina and 250- and 
140-kD core proteins in brain (Fig. 8). Even after exposure 
for an extended period, only one major band is seen in ret- 
ina (Fig. 8, second set of retina lanes). As expected, no im- 
munologically crossreactive material  is seen to enter the 
gels prior to chondroitin ABC lyase treatment. The anti- 
400-kD antibody recognizes a major constituent at 400 kD, 
seen only after chondroitin ABC lyase treatment of retina 
and  brain,  and  additional  components  in  the  retina  at 
~300  and 200 kD both before and  after treatment  with 
chondroitin ABC lyase. 
To  determine  if  the  250-kD  monomer  and  the  Gal- 
NAcPTase are  associated in vivo, El0  retina  tissue  was 
homogenized in  neutral  detergent  and  the  rapidly  sedi- 
menting material containing cadherin/GalNAcPTase/actin 
complexes  incubated  with  anti-GalNAcPTase  antibody. 
The resulting immunoprecipitates were examined for the 
presence of the 250-kD core protein and N-cadherin. Simi- 
larly, anti-250-kD immunoprecipitates were examined for 
the presence of the GalNAcPTase and N-cadherin. Immu- 
noprecipitates  prepared  using  anti-GalNAcPTase  anti- 
body 1Bll  contain the  250-kD core protein  and N-cad- 
herin (Fig.  9).  The polypeptide at ~140 kD detected by 
the  anti-250-kD antibody is not N-cadherin as anti-250- 
kD antibody does not recognize purified N-cadherin (not 
shown). Immunoprecipitates prepared using the anti-250- 
kD core protein antibody contain the GalNAcPTase and 
N-cadherin (Fig.  9). None of these molecules are precipi- 
tated by control antibodies (Fig. 9). Similar results are ob- 
tained whether the samples are treated with chondroitin 
ABC lyase before or after immunoprecipitation. 
Discussion 
We have shown that the embryonic chick retina cell sur- 
face GalNAcPTase interacts specifically with an endoge- 
nous proteoglycan with a 250-kD core protein but not with 
a  distinct proteoglycan with  a  400-kD core protein.  The 
native  250-kD monomer and  core protein  generated  by 
chondroitin ABC lyase treatment are equally active; how- 
ever, we have used the 250-kD core protein for the major- 
ity of our analyses, as it can be isolated in larger quantities 
(H. Ernst, M. K. B. Zanin, D. Everman, and S. Hoffman, 
manuscript submitted for publication). Binding of the 250- 
kD PG to the GalNAcPTase on cells initiates a signal cas- 
cade which culminates in the inhibition of homophilic cad- 
herin-mediated cell-cell adhesion and neurite outgrowth. 
Treatment of cells with PI-PLC, which releases the  Gal- 
NAcPTase from the cell surface, abolishes both of these 
effects although the cells  continue to express N-cadherin 
and exhibit N-cadherin-mediated adhesion. Radiolabeled 
Figure 8. Presence of the 250- and 400-kD PG's in E9 chick retina 
and brain. Tissue extracts were prepared  and, where indicated, 
treated with chondroitin ABC lyase (Ch-ase).  Samples were then 
fractionated  by SDS-PAGE and immunoblotted  with the  indi- 
cated anti-proteoglycan core protein  antibodies. All lanes were 
loaded with 25 Ixg of extract. The second set of retina lanes blot- 
ted with anti-250 was exposed for 5x longer to match the inten- 
sity of the signal in the brain. The migration of standard proteins 
is indicated on the left by their molecular mass. The migration of 
the 400-kD component of laminin (not shown) was also used as a 
standard  in estimating the molecular mass of the core proteins 
larger than 200 kD. 
Figure 9. Coprecipitation of the GalNAcPTase, the 250-kD core 
protein,  and  N-cadherin  from  tissue. The  rapidly  sedimenting 
fraction from neutral detergent extracts of El0 neural retina was 
treated with chondroitin ABC lyase and incubated with anti-Gal- 
NAcPTase mAb 1Bll, nonimmune mouse IgM (Co), anti-250- 
kD core protein  antibody, or nonimmune rabbit IgG (Co). The 
resulting immunoprecipitates were fractionated by SDS-PAGE, 
transferred to Immobilon, and immunoblotted with anti-250-kD 
core protein  antibody, anti-GalNAcPTase mAb 1Bll and anti- 
N-cadherin mAb NCD-2. The migration of standard proteins is 
indicated on the left by their molecular mass. 
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by anti-GalNAcPTase mAb  1Bll,  but  not  by anti-Gal- 
NAcPTase mAb 7A2. This observation, and the fact that 
the  binding  of  mAb  1Bll,  but  not  7A2,  to  the  Gal- 
NAcPTase also inhibits cadherin mediated adhesion (Bal- 
samo et al., 1991), strongly suggests that both the 250-kD 
PG and mAb 1Bll bind to an overlapping epitope on the 
GalNAcPTase. Binding between the 250-kD core protein 
and the GalNAcPTase can also be demonstrated directly; 
GalNAcPTase liberated from cells by PI-PLC treatment 
binds to immobilized 250-kD core protein but not to im- 
mobilized 400-kD core protein. Finally, our data indicate 
that binding of the 250-kD core protein or mAb 1Bll to 
the GalNAcPTase leads to enhanced tyrosine phosphory- 
lation of 13-catenin. This, in turn, inhibits the association of 
N-cadherin with the actin-containing cytoskeleton leading 
to the observed inhibition of cadherin-mediated adhesion 
and neurite outgrowth. 
This work describes a new regulatory mechanism poten- 
tially important  in  controlling cadherin-dependent mor- 
phogenetic processes; binding  of the  250-kD  PG to  the 
GalNAcPTase resulting in loss of cadherin function. Our 
working hypothesis is that the temporal and spatial regula- 
tion of the expression of the GalNAcPTase and of the 250- 
kD PG plays a role in the control of morphogenesis by in- 
hibiting  cadherin  function  at  certain  select  times  and 
places during development. Consistent with this idea, the 
GalNAcPTase  and  the  250-kD  PG  are  developmentally 
regulated. The GalNAcPTase is initially found throughout 
the chick eye but gradually becomes localized to the fiber 
layer and  outer  segments  (Balsamo  et  al.,  1986)  and is 
found  in  the  outer  segments  of  all  vertebrates  tested 
(Sweatt et al., 1991). It is also present at the mature neuro- 
muscular junction, where its localization is controlled by 
innervation (Scott et al., 1990). During early development, 
the GalNAcPTase is localized to the dorsal neural tube 
and notochord, suggesting an important function in neu- 
ronal induction and development (J. Balsamo and J. Lil- 
ien, unpublished observation). 
The distribution of the 250- and 400-kD PG's are also 
regulated in time and space. In the developing retina, anti- 
250- and anti-400-kD stain fiber layers beginning at El0 
(A. Sweat, S. Hoffman, J. Balsamo, and J. Lilien, unpub- 
lished  observation). In  the  4-d-old embryo several  sites 
have been identified where the 250- and the 400-kD PG's 
appear to have mutually exclusive distributions (M. K. B. 
Zanin,  H.  Ernst  and  S.  Hoffman, unpublished  observa- 
tion). For example, in  the  heart, anti-250  stains  the en- 
docardial surface of the myocardium; in contrast, anti-400 
stains the endocardial cushion tissue, particularly the por- 
tion of loosely packed cells nearest the myocardium. 
Our data also suggest an additional mode through which 
the inhibitory function of the 250-kD  PG may be regu- 
lated. The active form of the proteoglycan is the mono- 
meric form; macromolecular complexes of proteoglycan 
monomers bound non-covalently to hyaluronic acid (i.e., 
proteoglycan aggregates) are inactive. While the monomer 
is the most abundant form of the 250-kD PG in E14 brain, 
we have no information on the relative abundance of ag- 
gregates  and  monomers at  other stages  of development 
and in other tissues. These observations raise the possibil- 
ity that the interaction of the 250-kD PG with hyaluronic 
acid  may  interfere with  its  ability  to  bind  to  the  Gal- 
NAcPTase. If so, the regulated expression of hyaluronic 
acid or hyaluronidase in vivo may, in turn, regulate the in- 
teraction of the  250-kD PG  and  the  GalNAcPTase  and 
thus cadherin-mediated adhesion. 
Regulation of adhesion may also occur through the in- 
teraction of the GalNAcPTase with multiple ligands at dif- 
ferent times and places during development. It is currently 
unknown what structural features of the 250-kD PG are 
required for interaction with the GalNAcPTase. While it is 
clear that  the  bulk  of the  chondroitin sulfate  is  not re- 
quired, we do not know whether the remaining carbohy- 
drate in the 250-kD core protein or the polypeptide por- 
tion  is  responsible  for  its  specific  interaction  with  the 
GalNAcPTase. If the carbohydrate portion of the 250-kD 
core protein is involved in binding to the GalNAcPTase, 
the possibility must be considered that similar oligosaccha- 
rides are present on additional proteoglycans or glycopro- 
teins.  Furthermore,  the  distribution  of oligosaccharides 
able to interact with the GalNAcPTase could further be 
altered by the patterned expression of other glycosyltrans- 
ferases and glycosidases. Alteration of oligosaccharides on 
ECM molecules affecting their biological activity is consis- 
tent with observed differences in cell spreading on lami- 
nin, before and after glycosylation of the laminin by ga- 
lactosyltransferase  (Runyan  et  al.,  1988),  and  with  the 
observed inhibition of the ability of mesenchymal cells to 
migrate through a three-dimensional collagen gel if similar 
cells  have  already  passed  through  and  thereby  "condi- 
tioned" the gel (Markwald et al., 1984). The 250- and 400- 
kD  core proteins used  in this  study bind cytotactin (H. 
Ernst, M. K. B. Zanin, and S. Hoffman; unpublished). The 
original cytotactin-binding (CTB) proteoglycan (Hoffman 
and Edelman, 1987) was reported to have a 280-kD core; 
using laminin as a standard, we now estimate the molecu- 
lar mass of this core protein to be 400 kD. Recently, the 
proteoglycans neurocan and phosphacan  (Grumet et al., 
1994) have been reported to bind to cytotactin (tenascin); 
it has also been suggested that versican may be a  "CTB 
proteoglycan" (Perides et al., 1993). While it is noteworthy 
that the 250-kD core protein binds to cytotactin, it is un- 
likely that this activity is involved in its ability to bind to 
the GalNAcPTase because the 400-kD core protein also 
binds to cytotactin but not to the GalNAcPTase. The gly- 
coprotein restrictin, which is structurally related to cyto- 
tactin (N6renberg et al., 1992), is associated with our pro- 
teoglycan aggregates  and native  monomer preparations. 
Our  recent  results  suggest  that  this  association  occurs 
because  restrictin  also  binds  proteoglycans  (H.  Ernst, 
M. K. B.  Zanin,  and  S.  Hoffman, unpublished  observa- 
tion). Restrictin also does not appear to be involved in the 
inhibition  of  cadherin-mediated  adhesion;  the  250-kD 
monomer and the 250-kD core protein preparations that 
are fully active in inhibiting cadherin-mediated adhesion 
are free of restrictin. 
Recently we have succeeded in determining the NH2- 
terminal sequences of at least 13 CNBr fragments derived 
from our 250- and 400-kD core protein preparations (H. 
Ernst, M. K. B. Zanin and S. Hoffman; unpublished obser- 
vations). Although both the 250- and the 400-kD core pro- 
teins appear as well-resolved sharp bands on Coomassie 
blue-stained  gels,  comparison  of  these  data  to  the  se- 
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zer, 1992) and chicken versican (Shinomura et al.,  1993) 
and to the sequences of rat neurocan (Rauch et al., 1992) 
and phosphacan (Maurel et al., 1994) suggest that both the 
250- and the 400-kD core proteins are mixtures of known 
proteoglycans. The 250-kD core protein preparation ap- 
pears  to  contain  neurocan,  phosphacan,  and  aggrecan. 
This size is consistent with the known molecular mass of 
the neurocan core protein and suggests that partial degra- 
dation  of phosphacan  and  aggrecan may occur creating 
fragments  in  this  size  range.  The  400-kD  core  protein 
preparation appears to contain phosphacan, versican, and 
aggrecan which is consistent with the reported molecular 
weights for these proteoglycans. All of the NH2-terminal 
sequences that we obtained could be accounted for by one 
of these four proteoglycans, suggesting that there are no 
novel proteoglycans in our preparations. As neurocan is 
the  only proteoglycan found  exclusively in  the  250-kD 
core protein preparation, and only this core protein prepa- 
ration is active in our assays, it is likely that neurocan is the 
proteoglycan that binds to the  GalNAcPTase leading to 
the inhibition of cadherin-mediated adhesion. 
These data are totally consistent with the specificity of 
the  anti-250  and  anti-400  antibodies.  The  anti-250  anti- 
body was isolated on the basis of its ability to bind to the 
immobilized 250-kD core protein and not the 400-kD core 
protein. Because neurocan is unique to the 250-kD core 
protein preparation, an antibody prepared in this manner 
should be an anti-neurocan antibody. Like anti-neurocan 
antibodies (Rauch et al.,  1992), the anti-250 recognizes a 
brain proteoglycan with a 140-kD core protein in addition 
to the full-length 250-kD core protein. The fact that the 
anti-250 has the specificity appropriate for an anti-neuro- 
can  antibody, and  also  immunoprecipitates from retinal 
tissue extracts a 250-kD proteoglycan along with the Gal- 
NAcPTase, is further evidence that neurocan is likely to 
be the proteoglycan that interacts with the GalNAcPTase. 
It is interesting to note that, if our speculation that the 
250-kD PG is neurocan is correct, neurocan has the poten- 
tial to interact with multiple molecules at different times 
and places during development. The 250-kD PG interacts 
with  cytotactin, restrictin, hyaluronic acid,  and  the  Gal- 
NAcPTase,  while neurocan  (and phosphacan)  has  been 
reported to bind directly to N-CAM and Ng-CAM, inhib- 
iting N-CAM-to-N-CAM and Ng-CAM-to-Ng-CAM-medi- 
ated  adhesion  (Grumet  et  al.,  1993;  Friedlander  et  al., 
1994).  This mechanism of inhibition of adhesion is, how- 
ever, quite distinct from that demonstrated here. The 250- 
kD  core  protein  cannot  be  functioning  by  binding  to 
N-CAM or Ng-CAM in our experiments because the pro- 
cedure used to prepare single cells, trypsinization in the 
presence of calcium, strips the cell surface of N-CAM and 
Ng-CAM and leaves the ceils unable to adhere through a 
calcium-independent mechanism  (Grunwald  et al.,  1980; 
Brackenbury et al., 1981; Magnani et al., 1981).  However, 
cells prepared in this manner have intact and functional 
N-cadherin and GalNAcPTase at their surface (Balsamo 
and Lilien, 1982, 1990). 
The most plausible explanation for the inhibition of cad- 
herin function on binding of the 250-kD PG to the Gal- 
NAcPTase is that a signaling pathway is activated which 
culminates in the dissociation of cadherin from the actin- 
containing cytoskeleton. As with the binding of anti-Gal- 
NAcPTase  mAb  1Bll  (Balsamo  et  al.,  1991),  we  have 
found that the association of cadherin with the cytoskele- 
ton is uncoupled following binding of the 250-kD PG to 
the GalNAcPTase. The association of cadherins with the 
cytoskeleton has been shown to be essential to cadherin 
function by several techniques, most convincingly by dele- 
tion  of the  cytoplasmic domain  of cadherin  (Nagafuchi 
and Takeichi, 1988, 1989; Kintner, 1992)  and through the 
transfection into cells of a  truncated, dominant negative 
construct containing only the cytoplasmic domain of cad- 
herin  (Fujimori  and  Takeichi,  1993).  In  both  of  these 
cases, cadherin continues to be expressed at the cell sur- 
face, but function is lost. Interestingly, the interaction of 
the 250-kD PG (and the 400-kD PG) with its receptor(s) 
on fibroblasts also initiates a signal cascade affecting adhe- 
sion molecule function through alterations at the level of 
the cytoskeleton, resulting in the failure to spread on fi- 
bronectin and vitronectin, and the failure to phosphorylate 
the focal adhesion kinase (H. Ernst, M. K. B. Zanin, D. 
Everman, and S. Hoffman, manuscript submitted for pub- 
lication). 
Cadherin interaction with actin is mediated by a-, 13- and 
~/-catenin (Ozawa et al., 1989). a-catenin is related to vin- 
culin (Herrenknecht et al.,  1991;  Nagafuchi  et al.,  1991) 
and  13- and ",/-catenins  are  related to the product of the 
Drosophila segment polarity gene armadillo  (McCrea et 
al.,  1991; Peifer et al., 1992) and to plakoglobin (Butz et 
al.,  1992;  Knudsen  and  Wheelock,  1992).  Aberrant  or 
missing  a-catenin  (Shimoyama  et  al.,  1992;  Oda  et  al., 
1993) and phosphorylation of 13-catenin (Matsuyoshi et al., 
1992;  Behrens et al.,  1993;  Hamaguchi et al.,  1993;  Shi- 
bamoto  et  al.,  1994)  have  been  correlated with  loss  of 
cadherin function. Consistent with these observations, we 
have found that binding of the 250-kD PG or anti-Gal- 
NAcPTase mAb 1Bll to cells results in increased levels of 
phosphorylated tyrosine in [3-catenin.  This further estab- 
lishes the link between the presence of phosphorylated ty- 
rosine residues on [3-catenin and the loss of cadherin func- 
tion. Thus, cadherin-dependent morphogenetic processes 
may be controlled by several distinct physiological signals, 
one of which is the interaction of the 250-kD PG with the 
GalNAcPTase, and  all  of which initiate  signal  cascades 
that regulate the level of phosphorylated tyrosine residues 
in 13-catenin and thereby cadherin function. 
Portions  of  this  work  were  supported  by  a  grant  from  the  Greenville 
Hospital/Clemson University Cooperative Research Program to J. Lilien 
while at Clemson University and by National Institutes of Health grant 
HL37641 to S. Hoffman. 
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